Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 3,200.00
-30.00 (-0.93%)
At close: Apr 9, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 300.97 billion as of April 10, 2026. Its market cap has increased by 141.86% in one year.
Market Cap
300.97B
Enterprise Value
272.22B
Revenue
3.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,200.00
Market Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 300.97B, an increase of 132.72%. That is a compound annual growth rate of 8.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 303.79B | 39.22% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 315.79B |
| curacle co.,ltd. | 297.62B |
| NIBEC | 291.54B |
| Bio Solution | 270.01B |
| Genome & Company | 236.57B |
| ABION | 197.77B |
| ISU Abxis | 181.62B |
| Prestige Biologics | 180.00B |